Recent Updates
Recently added Catalysts
VNDA Neutral Sentiment

Vanda Pharmaceuticals to Announce Third Quarter 2023 Financial Results on November 8, 2023

Wednesday, November 1, 2023 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Vanda Pharmaceuticals has announced that it will release its financial results for the third quarter of 2023 on November 8, 2023, after the market closes. The company will host a conference call at 4:30 PM ET the same day to discuss these results and other corporate activities. Investors can join the call and access a replay via provided phone numbers and the company's website.
Price reaction · baseline $4.38 (2023-10-31 close) · hit after-hours · clean, no other VNDA news in the window
day 0 close · peak
-0.2%

Market Sentiment Analysis

POSITIVE FACTORS

  • Vanda Pharmaceuticals will release its third-quarter results.
  • The company has scheduled a conference call to discuss their financial results.
  • The call will be accessible via a broadcast on the company's website.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+121%
120-day peak, hindsight
Typical move
19.9%
average across 7 past catalysts
Cash runway
~16 mo
Low dilution risk
Lead asset
Imsidolimab
Phase 2 · Palmoplantar Pustulosis

Full Press Release Details

Conference Call and Webcast to Follow
WASHINGTON, Nov. 1, 2023 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced it will release results for the third quarter 2023 on Wednesday, November 8, 2023, after the market closes.
Vanda will host a conference call at 4:30 PM ET on Wednesday, November 8, 2023, during which management will discuss the third quarter 2023 financial results and other corporate activities. To participate in the conference call, please dial 1-800-715-9871 (domestic) or 1-646-307-1963 (international) and use passcode 9774278.
The conference call will be broadcast simultaneously and archived on Vanda's website, www.vandapharma.com. Investors should go to the website at least 15 minutes early to register, download, and install any necessary audio software.
A replay of the call will be available on Wednesday, November 8, 2023, beginning at 8:30 PM ET and will be accessible until Wednesday, November 15, 2023, at 8:30 PM ET. The replay call-in number is 1-800-770-2030 for domestic callers and 1-609-800-9909 for international callers. The passcode number is 9774278.
About Vanda Pharmaceuticals Inc.
Senior Vice President, Chief Financial Officer and Treasurer
Vanda Pharmaceuticals Inc.

Frequently Asked Questions

When will Vanda Pharmaceuticals release Q3 2023 results?

Vanda Pharmaceuticals will release Q3 2023 results on November 8, 2023.

What time is the conference call on November 8, 2023?

The conference call is scheduled for 4:30 PM ET on November 8, 2023.

How can I access the conference call?

To join, call 1-800-715-9871 for domestic or 1-646-307-1963 for international.

When will the replay of the call be available?

The replay will be available starting at 8:30 PM ET on November 8, 2023.

What is the passcode for the conference call?

The passcode to use is 9774278 for both the call and its replay.

ShareAdd on Google
Tags: VNDA Viatris Investor Conferences Healthcare Vanda Pharmaceuticals Q3 2023 results conference call financial results
Last updated: Nov 1, 2023

Biotech snapshot

Cash runway
$170M liquidity · $10M/mo burn
~16 mo
Low dilution risk
Lead asset
ImsidolimabPhase 2
Palmoplantar Pustulosis →

Catalyst track record

+121%
best trade around VNDA's most recent catalyst

Peak hindsight return over a 120-day window, across 7 tracked FDA/PDUFA catalysts for VNDA.

See every catalyst's timing & PoA →